.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

ACUTECT Drug Profile

« Back to Dashboard
Acutect is a drug marketed by Cis Bio Intl Sa and is included in one NDA.

The generic ingredient in ACUTECT is technetium tc-99m apcitide. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m apcitide profile page.

Summary for Tradename: ACUTECT

Patents:0
Applicants:1
NDAs:1

Clinical Trials for: ACUTECT

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cis Bio Intl Sa
ACUTECT
technetium tc-99m apcitide
INJECTABLE;INJECTION020887-001Sep 14, 1998DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ACUTECT

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cis Bio Intl Sa
ACUTECT
technetium tc-99m apcitide
INJECTABLE;INJECTION020887-001Sep 14, 19985,443,815<disabled>
Cis Bio Intl Sa
ACUTECT
technetium tc-99m apcitide
INJECTABLE;INJECTION020887-001Sep 14, 19985,645,815<disabled>
Cis Bio Intl Sa
ACUTECT
technetium tc-99m apcitide
INJECTABLE;INJECTION020887-001Sep 14, 19985,508,020<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc